GXP CONSULTING Switzerland Revenue and Competitors

Lausanne, Switzerland

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • GXP CONSULTING Switzerland's estimated annual revenue is currently $9.4M per year.(i)
  • GXP CONSULTING Switzerland's estimated revenue per employee is $201,000

Employee Data

  • GXP CONSULTING Switzerland has 47 Employees.(i)
  • GXP CONSULTING Switzerland grew their employee count by -10% last year.

GXP CONSULTING Switzerland's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.4M47-10%N/AN/A
#2
$182.5M90817%N/AN/A
#3
$48.4M24119%N/AN/A
#4
$297.3M1479-24%N/AN/A
#5
$152M7567%N/AN/A
#6
$170.6M849-9%N/AN/A
#7
$20.1M10027%N/AN/A
#8
$18.7M9313%N/AN/A
#9
$25.1M12518%N/AN/A
#10
$13.1M65-4%N/AN/A
Add Company

What Is GXP CONSULTING Switzerland?

Are you passioned about the Life Sciences? Are you ready to make a difference? Do you feel excited about the opportunity to collaborate and share your expertise with our industry leaders? YES? SO DO WE! GXP CONSULTING Switzerland is a swiss consulting company with a passioned team of Life Sciences professionals. Since 2014 we deliver outstanding industry's expertise and support to our clients in the complete range of product life cycle in the following areas: Quality Assurance, Qualification/Validation, Regulatory Affairs, Operational Excellence, Engineering, Manufacturing and Maintenance and Project Management. Learn more about us by visiting our webpage www.gxp-cs.com

keywords:N/A

N/A

Total Funding

47

Number of Employees

$9.4M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

GXP CONSULTING Switzerland News

2022-04-06 - Genedata Expressionist® 16.0 Provides Enhanced In-Depth Characterization and GxP Compliance Capabilities

BASEL, Switzerland (PRWEB) April 11, 2022 ... of quality monitoring processes, this release also provides new GxP-compliance capabilities.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.4M472%N/A
#2
$5.6M48-29%N/A
#3
N/A4923%N/A
#4
$8.9M492%N/A
#5
$7.6M49N/AN/A